Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
Open Access
- 17 June 2022
- journal article
- review article
- Published by Springer Nature in Cancer Cell International
- Vol. 22 (1) , 1-12
Abstract
MIR4435-2HG (LINC00978) is a long non-coding RNA (lncRNA) that acts as an oncogene in almost all cancers. This lncRNA participates in the molecular cascades involved in other disorders such as coronary artery diseases, osteonecrosis, osteoarthritis, osteoporosis, and periodontitis. MIR4435-2HG exerts its functions via the spectrum of different mechanisms, including inhibition of apoptosis, sponging microRNAs (miRNAs), promoting cell proliferation, increasing cell invasion and migration, and enhancing epithelial to mesenchymal transition (EMT). MIR4435-2HG can regulate several signaling pathways, including Wnt, TGF-β/SMAD, Nrf2/HO-1, PI3K/AKT, MAPK/ERK, and FAK/AKT/β‑catenin signaling pathways; therefore, it can lead to tumor progression. In the present review, we aimed to discuss the potential roles of lncRNA MIR4435-2HG in developing cancerous and non-cancerous conditions. Due to its pivotal role in different disorders, this lncRNA can serve as a potential biomarker in future investigations. Moreover, it may serve as a potential therapeutic target for the treatment of various diseases.Keywords
This publication has 91 references indexed in Scilit:
- The emerging role of lncRNAs in cancerNature Medicine, 2015
- Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancerTumor Biology, 2015
- A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancerToxicology and Applied Pharmacology, 2015
- Long noncoding RNAs and the genetics of cancerBritish Journal of Cancer, 2013
- TGF-β signalling and its role in cancer progression and metastasisCancer and Metastasis Reviews, 2012
- The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1Oncogene, 2009
- Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal TransitionCancer Cell, 2009
- Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbitsJoint Bone Spine, 2008
- BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast DifferentiationJournal of Biological Chemistry, 2008
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2Carcinogenesis, 2008